Defiance Daily Target 2X Long LLY ETF (LLYX)

NYSEARCA: LLYX · Real-Time Price · USD
15.54
-0.22 (-1.40%)
At close: Oct 29, 2025, 4:00 PM EDT
16.35
+0.81 (5.21%)
Pre-market: Oct 30, 2025, 9:26 AM EDT
-1.40%
Assets$54.67M
Expense Ratio1.32%
PE Ration/a
Shares Out3.42M
Dividend (ttm)n/a
Dividend Yieldn/a
Ex-Dividend Daten/a
Payout Frequencyn/a
Payout Ration/a
Volume1,107,314
Open16.01
Previous Close15.76
Day's Range15.35 - 16.14
52-Week Low9.60
52-Week High26.17
Betan/a
Holdings11
Inception DateAug 7, 2024

About LLYX

Fund Home Page

The Defiance Daily Target 2X Long LLY ETF (LLYX) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide 2x leveraged exposure to the daily share price movement of the Eli Lilly and Company (NYSE: LLY), less fees and expenses. LLYX was launched on Aug 7, 2024 and is issued by Defiance.

Asset Class Equity
Category Trading--Leveraged Equity
Stock Exchange NYSEARCA
Ticker Symbol LLYX
ETF Provider Defiance

Top 10 Holdings

265.05% of assets
NameSymbolWeight
LLY SWAP NOMURAn/a68.63%
ELI LILLY & CO SWAP CSn/a44.37%
ELI LILLY & CO SWAP Cantor - Ln/a41.92%
ELI LILLY & CO SWAP MAREXn/a39.56%
US DOLLARSn/a29.61%
DEPOSITS WITH BROKER FOR SHORT POSITIONSn/a19.47%
United States Treasury Bills 0%B.0 10.28.2512.80%
ELI LILLY & CO SWAP MSn/a5.29%
United States Treasury Bills 0%B.0 11.20.253.38%
First American Government Obligations FundFGXXX0.02%
View More Holdings

Performance

LLYX had a total return of -39.06% in the past year, including dividends. Since the fund's inception, the average annual return has been -29.02%.

News

There is no news available yet.